The investment forms part of the hospital’s broader strategy to expand access to next-generation medical technologies despite Lebanon’s ongoing healthcare and economic challenges.
LAUHS will manage the facility using its physician network, established medical protocols, and integrated healthcare model.
This initiative aligns with the Ministry’s National Cancer Plan 2023–2028 and represents a key step in advancing Lebanon’s cancer control strategy.
The agreement encompasses the manufacturing and supply of several Algorithm products licensed in the European Union and Japan.